Sandercock Colin

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sandercock Colin's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
129.88
Quantity 97,318 -3.3%
Value US$3,708,978
Transaction date
Planned sale
Price
59.62
Quantity 10,083 -48.6%
Value US$768,068
Transaction date
Planned sale
Price
402.04
Quantity 40,373 -27.3%
Value US$875,085
Transaction date
Purchase
Price
7.93
Quantity 14,938 +746.9%
Value US$118,458
Transaction date
Purchase
Price
7.10
Quantity 2,000 +inf%
Value US$14,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-07 2020-08-05
PlS Planned sale
97,318 -3.3%
129.88
US$3,708,978 		97,318 -3.3% 129.88 US$3,708,978
2020-08-05 2020-08-04
PlS Planned sale
10,083 -48.6%
59.62
US$768,068 		10,083 -48.6% 59.62 US$768,068
2020-08-05 2020-08-03
PlS Planned sale
40,373 -27.3%
402.04
US$875,085 		40,373 -27.3% 402.04 US$875,085
2019-06-10 2019-06-10
B Purchase
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06
B Purchase
2,000 +inf%
7.10
US$14,200 		2,000 +inf% 7.10 US$14,200